Innovation Strategies and Competitive Advantage of Manufacturing Pharmaceutical Companies in Nairobi, Kenya
Abstract
The growing number of traditional and herbal medicinal products has increased
competition for pharmaceutical companies too. About 70% of the population in
Kenya relies on traditional medicine. This trend is worrying to the entire
pharmaceutical industry especially those manufacturing pharmaceutical companies. It
is a threat to their competitive advantage and long-term survival. The study examined
the link between innovation strategies and competitive advantage among companies
engaged in the manufacture of health care products. The design adopted was
descriptive. The population comprised of 22 manufacturing pharmaceutical
companies in Nairobi. The study adopted a census on all the 22 companies. Data for
the study was sought by the use of questionnaires. The presentation of the findings
was done using tables. The study established that (88.0%) change in competitive
advantage of the studied manufacturing pharmaceutical companies is explained by
their innovation strategies in place (process, product, technology and market
innovation). The study concludes that innovation strategies significantly influence
competitive advantage. As a recommendation, the management of all manufacturing
pharmaceutical firms need to improve on their process, product and technology and
market innovation in order to significantly influence competitive advantage of their
companies. Policy makers including the ministry of health and the PPB of Kenya
should create a conducive environment that encourage and support innovation among
manufacturing pharmaceutical companies.
Publisher
university of nairobi
Rights
Attribution-NonCommercial-NoDerivs 3.0 United StatesUsage Rights
http://creativecommons.org/licenses/by-nc-nd/3.0/us/Collections
The following license files are associated with this item: